carbamates has been researched along with Depression in 40 studies
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to determine the involvement of the endocannabinoid system in anxiety- and depression-related behaviors in methamphetamine-withdrawal male NMRI mice." | 4.02 | URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels. ( Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR, 2021) |
| "In all subjects, SJW had no effect on the total area under the plasma concentration-time curve from time zero to infinity (AUC(∞)), the peak plasma concentration (C(max)) or the elimination half-life (t(½)) of repaglinide." | 2.76 | The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide. ( Chen, WQ; Fan, L; Guo, D; Liu, YL; Liu, ZQ; Sheng, D; Tan, ZR; Zhang, W; Zhou, G; Zhou, HH, 2011) |
| "While insulin resistance is common in older people, large numbers also have impaired insulin secretion." | 2.40 | The elderly Type 2 diabetic patient: special considerations. ( Morley, JE, 1998) |
| "Neuropathic pain is often associated with depression." | 1.51 | Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain. ( Gong, DY; Hai, KR; Jiang, HX; Ke, BW; Liu, J; Ma, G; Yang, Z; Zhou, C, 2019) |
| "Posttraumatic stress disorder (PTSD) is a debilitating condition highly comorbid with depression." | 1.48 | Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. ( Akirav, I; Burstein, O; Doron, R; Shoshan, N, 2018) |
| "Remarkably, the long-lasting widespread hyperalgesia induced by combining CUS and NGF was effectively reduced by URB597, but not by JZL184." | 1.42 | Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. ( Bindila, L; Hoheisel, U; Lerner, R; Lomazzo, E; Lutz, B; Remmers, F; Schwitter, C, 2015) |
| "05-10 μg/mouse) produced antidepressant-like effect dose-dependently, whereas influenced the MBB in a biphasic manner (produced a U-shaped dose-response curve)." | 1.37 | Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice. ( Jain, NS; Manna, SS; Umathe, SN, 2011) |
| "Treatments in Alzheimer's disease include treatment of cognitive impairment and behavioral manifestations (agitation, depression, anxiety, delusions)." | 1.30 | [Drug therapy strategies in Alzheimer's disease]. ( Lacomblez, L, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (42.50) | 18.7374 |
| 1990's | 2 (5.00) | 18.2507 |
| 2000's | 5 (12.50) | 29.6817 |
| 2010's | 11 (27.50) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Krystal, AD | 1 |
| Benca, RM | 1 |
| Rosenberg, R | 1 |
| Schweitzer, PK | 1 |
| Malhotra, A | 1 |
| Babson, K | 1 |
| Lee, L | 1 |
| Bujanover, S | 1 |
| Strohl, KP | 1 |
| Maymon, N | 1 |
| Mizrachi Zer-Aviv, T | 2 |
| Sabban, EL | 1 |
| Akirav, I | 3 |
| Dong, B | 1 |
| Shilpa, BM | 1 |
| Shah, R | 1 |
| Goyal, A | 1 |
| Xie, S | 1 |
| Bakalian, MJ | 1 |
| Suckow, RF | 1 |
| Cooper, TB | 1 |
| Mann, JJ | 1 |
| Arango, V | 1 |
| Vinod, KY | 1 |
| Alteba, S | 1 |
| Tenenhaus, A | 1 |
| Ben David, G | 1 |
| Adelman, J | 1 |
| Hillard, CJ | 1 |
| Doron, R | 2 |
| Ebrahimi-Ghiri, M | 1 |
| Khakpai, F | 1 |
| Zarrindast, MR | 1 |
| Wei, H | 1 |
| Zhou, T | 1 |
| Tan, B | 1 |
| Zhang, L | 2 |
| Li, M | 1 |
| Xiao, Z | 1 |
| Xu, F | 1 |
| Burstein, O | 1 |
| Shoshan, N | 1 |
| Jiang, HX | 1 |
| Ke, BW | 1 |
| Liu, J | 1 |
| Ma, G | 1 |
| Hai, KR | 1 |
| Gong, DY | 1 |
| Yang, Z | 1 |
| Zhou, C | 1 |
| de Morais, H | 1 |
| Chaves, YC | 1 |
| Waltrick, APF | 1 |
| Jesus, CHA | 1 |
| Genaro, K | 1 |
| Crippa, JA | 1 |
| da Cunha, JM | 1 |
| Zanoveli, JM | 1 |
| Cuccurazzu, B | 1 |
| Zamberletti, E | 2 |
| Nazzaro, C | 1 |
| Prini, P | 1 |
| Trusel, M | 1 |
| Grilli, M | 1 |
| Parolaro, D | 1 |
| Tonini, R | 1 |
| Rubino, T | 2 |
| Kwilasz, AJ | 1 |
| Abdullah, RA | 1 |
| Poklis, JL | 1 |
| Lichtman, AH | 2 |
| Negus, SS | 1 |
| Meng, WQ | 1 |
| Lu, L | 1 |
| Xue, YS | 1 |
| Li, C | 1 |
| Zou, F | 1 |
| Liu, Y | 1 |
| Zhao, J | 1 |
| Lomazzo, E | 1 |
| Bindila, L | 1 |
| Remmers, F | 1 |
| Lerner, R | 1 |
| Schwitter, C | 1 |
| Hoheisel, U | 1 |
| Lutz, B | 1 |
| Simonnet, A | 1 |
| Cador, M | 1 |
| Caillé, S | 1 |
| Adamczyk, P | 1 |
| Gołda, A | 1 |
| McCreary, AC | 1 |
| Filip, M | 1 |
| Przegaliński, E | 1 |
| Umathe, SN | 1 |
| Manna, SS | 1 |
| Jain, NS | 1 |
| Fan, L | 1 |
| Zhou, G | 1 |
| Guo, D | 1 |
| Liu, YL | 1 |
| Chen, WQ | 1 |
| Liu, ZQ | 1 |
| Tan, ZR | 1 |
| Sheng, D | 1 |
| Zhou, HH | 1 |
| Zhang, W | 1 |
| ANTON, A | 1 |
| DONNADIEU, JM | 1 |
| BRADITCH, JL | 1 |
| DARBELLAY, J | 1 |
| CHESROW, EJ | 1 |
| KAPLITZ, SE | 1 |
| SABATINI, R | 1 |
| VETRA, H | 1 |
| MARQUARDT, GH | 1 |
| Piomelli, D | 1 |
| Tarzia, G | 1 |
| Duranti, A | 1 |
| Tontini, A | 1 |
| Mor, M | 1 |
| Compton, TR | 1 |
| Dasse, O | 1 |
| Monaghan, EP | 1 |
| Parrott, JA | 1 |
| Putman, D | 1 |
| Naidu, PS | 1 |
| Varvel, SA | 1 |
| Ahn, K | 1 |
| Cravatt, BF | 1 |
| Martin, BR | 1 |
| Trenité, DG | 1 |
| French, JA | 1 |
| Hirsch, E | 1 |
| Macher, JP | 1 |
| Meyer, BU | 1 |
| Grosse, PA | 1 |
| Abou-Khalil, BW | 1 |
| Rosenfeld, WE | 1 |
| van Gerven, J | 1 |
| Novak, GP | 1 |
| Parmeggiani, L | 1 |
| Schmidt, B | 1 |
| Gibson, D | 1 |
| Guerrini, R | 1 |
| McLaughlin, RJ | 1 |
| Hill, MN | 1 |
| Morrish, AC | 1 |
| Gorzalka, BB | 1 |
| Spry, WB | 1 |
| Lacomblez, L | 1 |
| Morley, JE | 1 |
| Cesa-Bianchi, M | 1 |
| Ghirardi, P | 1 |
| Ravaccia, F | 1 |
| Kissin, B | 1 |
| Gross, MM | 1 |
| de Oliveira, JM | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Bratfos, O | 1 |
| Lingjaerde, O | 1 |
| Salvesen, C | 1 |
| Rickels, K | 2 |
| Hesbacher, P | 1 |
| Vandervort, W | 1 |
| Phillips, F | 1 |
| Hutchison, J | 1 |
| Sablosky, L | 1 |
| Lavan, D | 1 |
| Hesbacher, PT | 1 |
| Weise, CC | 1 |
| Gray, B | 1 |
| Feldman, HS | 1 |
| Meshel, E | 1 |
| Denber, HC | 1 |
| Majeron, MA | 1 |
| Toselli, E | 1 |
| Solaro, F | 1 |
| Corletto, F | 1 |
| Coppen, A | 1 |
3 reviews available for carbamates and Depression
| Article | Year |
|---|---|
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
Topics: Amidohydrolases; Analgesics; Animals; Anxiety; Benzamides; Brain; Cannabinoids; Carbamates; Depressi | 2006 |
The elderly Type 2 diabetic patient: special considerations.
Topics: Aged; Amyloid; Blood Glucose; Carbamates; Cognition Disorders; Depression; Diabetes Mellitus, Type 2 | 1998 |
Pharmacotherapy of tension and anxiety.
Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe | 1972 |
9 trials available for carbamates and Depression
| Article | Year |
|---|---|
Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
Topics: Carbamates; Depression; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; | 2022 |
The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.
Topics: Carbamates; Cross-Over Studies; Cytochrome P-450 Enzyme System; Depression; Genotype; Herb-Drug Inte | 2011 |
Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.
Topics: Adolescent; Adult; Affect; Anticonvulsants; Carbamates; Depression; Dose-Response Relationship, Drug | 2007 |
A preliminary double-blind study with SB 5833 (camazepam), a new benzodiazepine derivative.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Carbamates; Clinical Trials as Topic; Depression; Dia | 1974 |
Pharmacotherapy of tension and anxiety.
Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe | 1972 |
Symptomatic relief of neurotic symptoms with tybamate: a doube-blind, placebo-controlled study.
Topics: Adult; Aged; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; Hysteria; Ma | 1967 |
Tybamate--a perplexing drug.
Topics: Adult; Anxiety Disorders; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; Middle A | 1968 |
Pills and improvement: a study of placebo response in psychoneurotic outpatients.
Topics: Adult; Amitriptyline; Anxiety Disorders; Carbamates; Clinical Trials as Topic; Depression; Family Pr | 1970 |
Double-blind study of tybamate in psychotic patients.
Topics: Adult; Aged; Aggression; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; | 1967 |
29 other studies available for carbamates and Depression
| Article | Year |
|---|---|
Neuropeptide Y and cannabinoids interaction in the amygdala after exposure to shock and reminders model of PTSD.
Topics: Amygdala; Animals; Arachidonic Acids; Arousal; Basolateral Nuclear Complex; Behavior, Animal; Benzam | 2020 |
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats.
Topics: Amidohydrolases; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Carbamates; Depressio | 2020 |
Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress.
Topics: Age Factors; Animals; Antidepressive Agents; Benzamides; Benzodioxoles; Carbamates; Depression; Fema | 2020 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; C | 2021 |
Impact of chronic unpredicted mild stress-induced depression on repaglinide fate via glucocorticoid signaling pathway.
Topics: Animals; Biosynthetic Pathways; Carbamates; Cell Line; Constitutive Androstane Receptor; Depression; | 2017 |
Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD.
Topics: Amidohydrolases; Animals; Benzamides; Benzoxazines; Brain-Derived Neurotrophic Factor; Cannabinoid R | 2018 |
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Depression; D | 2019 |
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats.
Topics: Animals; Antidepressive Agents; Benzamides; Cannabidiol; Carbamates; Depression; Diabetes Mellitus, | 2018 |
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling.
Topics: Adaptation, Psychological; Animals; Arachidonic Acids; Benzamides; Carbamates; Dentate Gyrus; Depres | 2018 |
Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
Topics: Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Behavior, Animal; Benzamides; Brain; Carbam | 2014 |
Selective detection of endogenous H₂S in living cells and the mouse hippocampus using a ratiometric fluorescent probe.
Topics: Animals; Carbamates; Cattle; Cystathionine beta-Synthase; Depression; Disease Models, Animal; Down-R | 2014 |
Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
Topics: Amidohydrolases; Analgesics, Non-Narcotic; Animals; Anxiety; Benzamides; Benzodioxoles; Brain; Carba | 2015 |
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Depression; Habenula; Male; Nicotine; Rats; Rats, | 2017 |
Activation of endocannabinoid transmission induces antidepressant-like effects in rats.
Topics: Animals; Antidepressive Agents; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carb | 2008 |
Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.
Topics: Animals; Antidepressive Agents; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carb | 2011 |
[Gamaquil (gamma-phenylpropylcarbamate) in neurological practice].
Topics: Anti-Anxiety Agents; Carbamates; Depression; Depressive Disorder; Muscular Diseases; Neurotic Disord | 1963 |
[Trial use of cyclarbamate in obstetrics].
Topics: Carbamates; Depression; Depressive Disorder; Female; Humans; Hyperemesis Gravidarum; Muscle Relaxant | 1963 |
[THE ORTHONEUROTIC EMYLCAMATE IN DAILY PRACTICE].
Topics: Alcoholism; Anxiety; Anxiety Disorders; Automobiles; Carbamates; Cats; Depression; Geriatrics; Mice; | 1963 |
A NEW PSYCHOTHERAPEUTIC AGENT EFFECTIVE IN THE MANAGEMENT OF GERIATRIC ANXIETY, DEPRESSION AND BEHAVIORAL REACTIONS.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Brain; Brain Damage, Chronic; Carbamates; Depressio | 1965 |
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Cannabinoid Rece | 2007 |
Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Cannabinoid Rece | 2007 |
Tybamate.
Topics: Anxiety; Carbamates; Depression; Humans; Tranquilizing Agents | 1967 |
Tybamate: a new tranquillizer.
Topics: Adolescent; Adult; Anxiety; Carbamates; Depression; Female; Humans; Male; Middle Aged; Tranquilizing | 1967 |
[Drug therapy strategies in Alzheimer's disease].
Topics: Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Car | 1998 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
[Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
Topics: Aged; Carbamates; Depression; Female; Humans; Intracranial Arteriosclerosis; Male; Mental Fatigue; M | 1970 |
[Clinical experience with a new tranquilizing agent: tybamate].
Topics: Aging; Anxiety Disorders; Carbamates; Depression; Evaluation Studies as Topic; Humans; Psychotic Dis | 1969 |
[Tybamate in the practice at geriatric outpatient clinics].
Topics: Aged; Anxiety; Brain Damage, Chronic; Carbamates; Depression; Female; Humans; Male; Middle Aged; Out | 1968 |
Mineral metabolism in affective disorders.
Topics: Biological Transport; Blood-Brain Barrier; Bromine; Carbamates; Depression; Humans; Lithium; Potassi | 1965 |